A single-probe isothermal amplification platform for point-of-care detection of circulating microRNAs in ophthalmic and oncological diseases.
文献摘要
The clinical demand for point-of-care (POC) detection of ophthalmic biomarkers, such as microRNA-21 (miR-21) for diabetic retinopathy (DR), is hampered by current assays that are often time-consuming, operationally complex, or prone to high background noise. To address this, we developed an ACH-based One-step Isothermal Instantaneous Cascade Amplification (ACH-OIICA) strategy. This platform relies on a single Autonomous Catalytic Hairpin (ACH) functioning as an "all-in-one" DNA nanomachine, which integrates target recognition, cascade amplification templating, and signal reporting, thereby eliminating the need for exogenous primers. Upon binding to miR-21, the ACH undergoes a conformational change that triggers a self-sustained cycle of polymerization and nicking, rapidly generating abundant G-quadruplex DNAzymes. The assay achieves a detection limit of 15.6 pM with a naked-eye distinguishable colorimetric readout. It demonstrates single-base specificity and robust performance in complex biological matrices. Crucially, ACH-OIICA proved its broad diagnostic utility across two distinct disease cohorts: it successfully differentiated patients with colorectal cancer (CRC) from healthy controls, and accurately distinguished patients with DR from healthy controls (HC). This work offers a streamlined, rapidly initiated, and highly sensitive platform, providing a robust framework for next-generation molecular diagnostics in clinical environment.